Transcriptomics

Dataset Information

0

STAT3 enhances sensitivity of glioblastoma to drug-induced autophagy-dependent lysosomal cell death


ABSTRACT: Glioblastoma (GBM) is a devastating disease and the most common primary brain malignancy of adults with a median survival barely exceeding one year. Recent findings suggest that the antipsychotic drug pimozide triggers an autophagy-dependent, lysosomal type of cell death in GBM cells with possible implications for GBM therapy. One oncoprotein that is often overactivated in these tumors and associated with a particularly dismal prognosis is Signal Transducer and Activator of Transcription 3 (STAT3). Here, we used isogenic human GBM knockout cell lines, advanced fluorescence microscopy, transcriptomic analysis and FACS-based assessment of cell viability to show that STAT3 has an underappreciated, context-dependent role in drug-induced cell death. Specifically, we demonstrate that depletion of STAT3 significantly enhances cell survival after treatment with pimozide, suggesting that STAT3 confers a particular vulnerability to GBM. Furthermore, we show that active STAT3 has no major influence on the early steps of the autophagy pathway, but exacerbates drug-induced lysosomal membrane permeabilisation (LMP) and release of cathepsins into the cytosol. Collectively, our findings support the concept of exploiting the pro-death functions of autophagy and LMP for GBM therapy and to further determine whether STAT3 can be employed as a treatment predictor for highly apoptosis-resistant, but autophagy-proficient cancers.

ORGANISM(S): Homo sapiens

PROVIDER: GSE162429 | GEO | 2022/01/13

REPOSITORIES: GEO

Similar Datasets

| PRJNA681849 | ENA
2016-08-04 | E-GEOD-79508 | biostudies-arrayexpress
2022-02-15 | PXD016675 | Pride
2016-08-04 | GSE79508 | GEO
2022-09-07 | PXD028852 | Pride
2021-02-26 | PXD015074 | Pride
2022-08-15 | GSE211227 | GEO
2023-07-19 | PXD043613 | Pride
2019-12-31 | GSE130625 | GEO
2022-06-13 | GSE205538 | GEO